Skip to main content
. 2019 May 31;27(9):1475–1480. doi: 10.1038/s41431-019-0430-5

Fig. 2.

Fig. 2

a Expression levels of chr14.232.a were increased following transfection of a plasmid expressing chr14.232.a in the proband’s skin fibroblasts. (*p < 0.05) b LRFN5 expression levels were significantly increased after chr14.232.a transfection in the proband’s skin fibroblasts. (*p < 0.05). c SiRNA knock-down of chr14.232.a decreased chr14.232.a expression in control fibroblasts (n = 5) (*p < 0.05). d LRFN5 expression levels were significantly reduced after transfection of siRNA targeting chr14.232.a in control fibroblasts (n = 5) (*p < 0.05)